Form D · Biotechnology
BIOCUREX INC
Richmond, A1 · CIK 0001092562
Offering snapshot reported Nov 9, 2009 · SEC filing
- Reported sold
- $2.15M Offering amount: $2.15M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $430K Reported outside-investor minimum
- First sale
- Aug 31, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 9, 2009 | Initial | $2,150,000 | No comparison | 2 | SEC filing |
| Oct 6, 2009 | Initial | $125,000 | No comparison | 3 | SEC filing |
| Sep 22, 2009 | Initial | $450,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-134622
Source: Form D, filed Nov 9, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Antonia Bold De Haughton | Director |
| Denis R Burger | Director, Executive |
| Gladys Chan | Executive |
| Phil Gold | Director |
| Ricardo Moro Vidal | Director, Executive |
| Jim Walsh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7080 River Rd Suite 215
Richmond, A1, V6X 1X5
Richmond, A1, V6X 1X5